Mobile Menu

Search Results

Search results for: ctDNA

Evaluation of ctDNA assays for precision oncology

An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]

Beyond companion diagnostics – what next for ctDNA liquid biopsy in the NHS?

Liquid biopsy has the promise to revolutionise cancer care and treatment, allowing the detection of rare cell types with a […]

ctDNA informs treatment in BRAF-mutated melanoma

Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]

NSCLC: Implementing ctDNA analysis in the clinic

A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]

ctDNA and metabolites in CSF serve as novel biomarkers for CNS germ cell tumours

Researchers have validated the use of circulating tumour DNA (ctDNA) and metabolites in cerebrospinal fluid (CSF) as potential biomarkers for […]

Liquid Biopsy ONLINE – October 2022

The advantages of non-invasive cancer testing are well known, yet routine clinical implementation is still a long way off. Despite […]

The Tri-Omics Summit USA

Front Line Genomics is pleased to announce the first Tri-Omics Summit in Boston, MA on 27th – 29th September 2022. […]

Genomics week in brief: Week ending 10th June

Check out the latest Genomics Week in Brief – full of intriguing news and research from the genomics space! Top […]

Liquid Biopsy ONLINE – June 2022

Join us for Liquid Biopsy ONLINE, a 3 part webinar series, where we explore the technologies behind liquid biopsies, their […]

Liquid biopsies offer faster and more accurate biomarker identification for bowel cancer patients

Written by Poppy Jayne Morgan A new study in ESMO Open has identified a faster and more accurate diagnosing tool […]